| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |